Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia

被引:35
|
作者
Younger, JG
Shankar-Sinha, S
Mickiewicz, M
Brinkman, AS
Valencia, GA
Sarma, JV
Younkin, EM
Standiford, TJ
Zetoune, FS
Ward, PA
机构
[1] Univ Michigan, Dept Emergency Med, Ann Arbor, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
关键词
D O I
10.1165/rcmb.2002-0145OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complement is necessary for defense against lung infection with Pseudomonas aeruginosa in mice. We studied in vitro interactions between complement and P. aeruginosa and in vivo effects of complement depletion to better understand this relationship. In vitro, P. aeruginosa strain UI-18 was resistant to killing by mouse serum. However, C3 opsonized the organism (via the alternative and mannose binding lectin [MBL] pathways), and C5 convertase activity on the bacterial surface was demonstrated. In vivo, compared with normal mice, complement-deficient mice experienced higher mortality and failed to sterilize their bronchoalveolar space within 24 h of inoculation. These changes did not seem to be a result of decreased inflammation because complement-deficient mice had normal neutrophil recruitment, greater lung myeloperoxidase content, and, by 24 h, a 35-fold higher level of the CXC chemokine KC. Lung static pressure-volume curves were abnormal in infected animals but were significantly more so in complement deficient mice. These data indicate that although P. aeruginosa is resistant to serum killing, C3 opsonization and C5 convertase assembly occur on its surface. This interaction in vivo plays a central role in host survival beyond just recruitment and activation of phagocytes and may serve to limit the inflammatory response to and tissue injury resulting from bacterial infection.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 50 条
  • [31] Microbiome Communities in Pseudomonas Aeruginosa Pneumonia
    Pickens, C.
    Hountras, P.
    Walter, J. M.
    Kruser, J. M.
    Qi, C.
    Singer, B. D.
    Green, S.
    Seed, P.
    Wunderink, R. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [32] Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
    Caffrey, Aisling R.
    Appaneal, Haley J.
    Liao, J. Xin
    Piehl, Emily C.
    Lopes, Vrishali
    Puzniak, Laura A.
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [33] Regulation of Caenorhabditis elegans and Pseudomonas aeruginosa machinery during interactions
    Vigneshkumar, Balasubramanian
    Pandian, Shunmugiah Karutha
    Balamurugan, Krishnaswamy
    ARCHIVES OF MICROBIOLOGY, 2012, 194 (04) : 229 - 242
  • [34] Regulation of Caenorhabditis elegans and Pseudomonas aeruginosa machinery during interactions
    Balasubramanian Vigneshkumar
    Shunmugiah Karutha Pandian
    Krishnaswamy Balamurugan
    Archives of Microbiology, 2012, 194 : 229 - 242
  • [35] Lung function and inflammation during murine Pseudomonas aeruginosa airway infection
    Woelbeling, Florian
    Munder, Antje
    Kerber-Momot, Tanja
    Neumann, Detlef
    Hennig, Christian
    Hansen, Gesine
    Tuemmler, Burkhard
    Baumann, Ulrich
    IMMUNOBIOLOGY, 2011, 216 (08) : 901 - 908
  • [36] Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa
    Berk, RS
    Dong, Z
    Alousi, S
    Kosir, MA
    Wang, YY
    Vlodavsky, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (04) : 1182 - 1187
  • [37] Transmissible Pseudomonas aeruginosa strains and their consequences
    Jones, A
    COLISTIN - NEW INSIGHTS AND PRACTICAL ISSUES, 2004, 258 : 25 - 31
  • [38] In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa
    Yamada, Koichi
    Yamamoto, Yoshihiro
    Yanagihara, Katsunori
    Araki, Nobuko
    Harada, Yosuke
    Morinaga, Yoshitomo
    Izumikawa, Koichi
    Kakeya, Hiroshi
    Hasegawa, Hiroo
    Kohno, Shigeru
    Kamihira, Shimeru
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (04) : 472 - 478
  • [39] Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model
    Thomsen, K.
    Christophersen, L.
    Bjarnsholt, T.
    Jensen, P. O.
    Moser, C.
    Hoiby, N.
    JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (02) : 171 - 178
  • [40] Staphylococcus Aureus Alpha-Toxin Potentiates Pseudomonas AerugINOSa Infection In A Murine Pneumonia Model
    Hilliard, J. J.
    Jones-Nelson, O.
    Cohen, T. S.
    Tkaczyk, C.
    DiGiandomenico, A.
    Stover, C. K.
    Sellman, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191